CervoMed (CRVO) Other Accumulated Expenses (2010 - 2025)

CervoMed has reported Other Accumulated Expenses for 15 years, with the latest figure at $2.1 million in Q1 2025.

• Quarterly Other Accumulated Expenses rose 47.81% year-over-year to $2.1 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2.1 million (up 47.81% YoY) and the FY2024 annual result came in at $2.4 million, up 22.48% from the prior year.
• Other Accumulated Expenses declined to $2.1 million in Q1 2025 per CRVO's latest filing, from $2.4 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.4 million in Q4 2024 and troughed at $532550.0 in Q2 2023.
• A 5-year average of $1.5 million and a median of $1.5 million in 2022 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2021 and 2023: Other Accumulated Expenses soared 295.74% in 2021, then slumped 68.09% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $2.0 million in 2021, then tumbled by 67.47% to $644252.0 in 2022, then jumped by 200.08% to $1.9 million in 2023, then increased by 22.48% to $2.4 million in 2024, then decreased by 12.05% to $2.1 million in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.1 million, $2.4 million, and $2.2 million for Q1 2025, Q4 2024, and Q3 2024 respectively.